Kevin Hon Luen Lau

Title: Kevin Hon Luen Lau: Innovator in Pharmaceutical Compounds

Introduction

Kevin Hon Luen Lau is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 2 patents to his name, Lau's work focuses on innovative solutions for medical treatments.

Latest Patents

Lau's latest patents include "N-9 substituted purine compounds, compositions and methods of use." This invention relates to compounds of Formula I, where specific variables are defined, and it also encompasses pharmaceutical compositions that utilize these compounds for therapeutic applications. Another significant patent is for "Pyrimidine compounds, compositions and methods of use." This patent discloses compounds of Formula I that are useful in modulating PIKK related kinase signaling, such as mTOR, and addresses treatments for diseases like cancer that are influenced by the dysregulation of the PIKK signaling pathway.

Career Highlights

Kevin Lau is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to focus on groundbreaking research that has the potential to impact patient care significantly.

Collaborations

Lau has collaborated with esteemed colleagues, including Joseph P. Lyssikatos and Zhonghua Pei. These partnerships have fostered an environment of innovation and have contributed to the advancement of their shared research goals.

Conclusion

Kevin Hon Luen Lau is a distinguished inventor whose work in pharmaceutical compounds is paving the way for new treatment options. His contributions to the field are noteworthy, and his patents reflect a commitment to advancing medical science.